Skip Navigation


NDT Advance Access originally published online on September 27, 2006
Nephrology Dialysis Transplantation 2006 21(12):3362-3363; doi:10.1093/ndt/gfl562
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/12/3362    most recent
gfl562v2
gfl562v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Related articles in NDT
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (1)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Ikizler, T. A.
Right arrow Articles by Himmelfarb, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ikizler, T. A.
Right arrow Articles by Himmelfarb, J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2006]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Trials and trade-offs in haemodialysis vascular access monitoring

Talat Alp Ikizler1 and Jonathan Himmelfarb2

1Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center, Nashville, TN and 2Department of Medicine, Division of Nephrology, Maine Medical Center, Portland, ME, USA

Correspondence and offprint requests to: T. Alp Ikizler, MD, Vanderbilt University Medical Center, 1161 21st Ave. South & Garland, Division of Nephrology, S-3223 MCN, Nashville, TN 37232-2372, USA. Email: alp.ikizler@vanderbilt.edu

Keywords: angioplasty; haemodialysis vascular access; monitoring; thrombosis

The first 10% of the full text of this article appears below.

There are currently more than 300 000 patients receiving haemodialysis in the US and similar numbers are estimated in Europe. Despite the recognition that vascular access is the ‘Achilles heel’ of the dialysis procedure, haemodialysis vascular access failure and related complications continue to be one of the most difficult obstacles in the optimal care of dialysis patients. In the US, haemodialysis vascular access procedures and complications account for more than 20% of hospitalizations of haemodialysis patients and result in more than $1 billion per year of government paid expenditures [1]. Additional, often unrecognized costs stem from missed treatments, the placement and use of dialysis catheters and the significant . . . [Full Text of this Article]



   Prevention of vascular access failure: what is the next step?
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related articles in NDT:

Impact of a quality improvement programme based on vascular access flow monitoring on costs, access occlusion and access failure
Edwin Wijnen, Nils Planken, Xavier Keuter, Jeroen P. Kooman, Jan H. M. Tordoir, Michiel W. de Haan, Karel M. L. Leunissen, and Frank van der Sande
NDT 2006 21: 3514-3519. [Abstract] [FREE Full Text]  



This article has been cited by other articles:


Home page
 Nephrol Dial TransplantHome page
P. Ponce, A. Mateus, and L. Santos
Anatomical correlation of a well-functioning access graft for haemodialysis
Nephrol. Dial. Transplant., February 1, 2009; 24(2): 535 - 538.
[Abstract] [Full Text] [PDF]

Home page
 NDT PlusHome page
E. Wijnen, F. M. van der Sande, J. H. M. Tordoir, J. P. Kooman, and K. M. L. Leunissen
Effect of online haemodialysis vascular access flow evaluation and pre-emptive intervention on the frequency of access thrombosis
NDT Plus, October 1, 2008; 1(5): 279 - 284.
[Abstract] [Full Text] [PDF]